• Homepage
  • Corporate News
  • PRICE INQUIRY No. SEMA 66/PR113719/2025 – being conducted as a market assessment study 
06 August 2025

PRICE INQUIRY No. SEMA 66/PR113719/2025 – being conducted as a market assessment study 

In connection with the implementation of the project entitled “Development of a universal fastresponse platform, based on RNA technology, ensuring the national drug and epidemiological safety” funded by the state budget from the Medical Research Agency, Zakłady Farmaceutyczne Polpharma S.A., are requesting bids for the provision of services for conducting analytical tests.

Details of the price inquiry can be found in the documents attached below.

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.